Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial.
John A ToddMarina EvangelouAntony J CutlerMarcin L PekalskiNeil M WalkerHelen E StevensLinsey PorterDeborah J SmythDaniel B RainbowRicardo C FerreiraLaura EspositoKara M D HunterKevin W LoudonKathryn IronsJennie H YangCharles J M BellHelen SchuilenburgJames HeywoodBen ChallisSankalpa NeupanePamela ClarkeGillian ColemanSarah DawsonDonna GoymerKaterina AnselmiovaJane KennetJudy BrownSarah L CaddyJia LuJane GreatorexIan GoodfellowChris WallaceTimothy I M TreeMark EvansAdrian P ManderSimon BondLinda S WickerFrank Waldron-LynchPublished in: PLoS medicine (2016)
ISRCTN Registry ISRCTN27852285; ClinicalTrials.gov NCT01827735.